0001171843-18-002408.txt : 20180402 0001171843-18-002408.hdr.sgml : 20180402 20180402094851 ACCESSION NUMBER: 0001171843-18-002408 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180328 FILED AS OF DATE: 20180402 DATE AS OF CHANGE: 20180402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Katz Richard D CENTRAL INDEX KEY: 0001293577 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 18727465 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 4 1 form4.xml OWNERSHIP DOCUMENT X0306 4 2018-03-28 0 0001105533 ARGOS THERAPEUTICS INC ARGS 0001293577 Katz Richard D 4505 EMPEROR BOULEVARD, SUITE 300 DURHAM NC 27703 0 1 0 0 Vice President and CFO Common Stock 2018-03-28 4 A 0 22629 0 A 32326 D The shares are subject to a lapsing right of repurchase by the issuer, which shall lapse as to 11,315 shares on June 15, 2018, and with respect to the remaining 11,314 shares on December 14, 2018, subject to the Reporting Person continuing to be an employee of the issuer through each such date. /s/ Lori R. Harrelson, attorney in fact 2018-03-30